Global pharma company Lupin Limited has received an “A-” leadership rating from CDP for its performance in climate change and water security.
Lupin prioritizes water security through sustainable management practices, including recycling and conservation, ensuring optimal usage and reducing waste, contributing to ecosystem health and community health.
The company emphasizes its sustainability framework, focusing on environmental stewardship, employee well-being, supply chain sustainability, and patient-centric innovation, the company said in a press release.
The 2024 CDP scores for climate and water have significantly improved from last year’s “B” and “C” ratings.
Ramesh Swaminathan, Executive Director, Global CFO, and Head, API Plus SBU, Lupin, said, “We are delighted to be recognized by CDP as a leader in corporate sustainability. This recognition underscores our commitment to addressing global environmental challenges through measurable action. We consider CDP scores as a critical aspect in advancing our efforts towards sustainability. Lupin will continue to lead by example, setting new standards and adopting best sustainable practices to serve our communities.”
As Lupin moves forward, it will continue to leverage advanced technologies and forge strategic partnerships to drive continuous improvement and achieve its long-term sustainability objectives.
Earlier this year, Lupin’s S&P Global ESG scores moved to 76 from 69 last year, above the industry average of 30 in the pharmaceuticals sector.
